2025

Researchers and students enthusiastically discussed the latest research at both posters and interactive tables during the IMB Science Fair 2026.

Cardiovascular researcher Jan Magnus Aronsen has been appointed as a member of the Scientific Advisory Board of Open Research Europe.

Ear infections lead to extensive use of antibiotics, which in turn contributes to antibiotic resistance. Professor Jukka Corander has now been awarded NOK 10 million to research a vaccine against the bacterium H. influenzae.

Improving the effectiveness, safety and precision of treatment for rheumatic diseases has been a central focus throughout Professor Espen A. Haavardsholm’s research career. He has now been awarded the 2026 Gleditsch Prize.

Professor Victor Greiff has received NOK 12 million in funding from the Research Council of Norway’s FRIPRO scheme for a project that aims to improve our understanding of how antibodies can be engineered. The research could ultimately support the development of medicines that are more precise and effective.

It is already known that the brain uses the hippocampus to form memories of place. Now, Koen Vervaeke has been awarded NOK 12 million to investigate the role of another brain area that is also involved.

Research on mental health has traditionally focused on the brain and on genes. Now, Laura Anne Wortinger has been awarded an ERC Starting Grant to investigate how life before birth may shape depression in mothers and mental health in children.

Junbai Wang is one of the researchers chosen to receive FRIPRO funding. His project integrates advanced data mining and machine learning methods with biophysical models to gain a better understanding of genome regulation in cancer.

UiO:Life Science’s innovation programme SPARK Norway is designed to help academic innovators to advance promising research into value creating solutions. By applying a unique process model including mentoring, education, market exposure and global networks, SPARK Norway helps transforming good ideas into exceptional solutions.

The incidence of inflammatory bowel disease (IBD) in Norway is rising. The new network Nordic NOIR will increase the quality of Norwegian IBD research through Nordic collaborations and better utilization of resources.

The professor is recognised for her groundbreaking work in autophagy and cancer, and for her central role in building a world-leading research environment at the University of Oslo. “I have always followed the paths where research has taken me,” the prize winner says.

The heart researcher is recognized for his outstanding efforts as a cardiac researcher. His commitment to clinical studies and the development of national research infrastructure, as well as his communication and teaching efforts have strengthened both the field and the recruitment of new talent.

The University of Oslo (UiO) is joining forces with leading universities, research institutions and industry in a major medical initiative to develop countermeasures against the virus that causes the infectious diseases smallpox and mpox.

On 9 and 10 June, NCMBM gathered at the Klækken Hotel in Hønefoss for two days of scientific talks, networking and community building.

The two-day retreat brought together around 80 participants to exchange knowledge, strengthen collaborations and connect with colleagues across the Centre.

Research on new targets for immunotherapy against cancer, better methods for pain relief in prehospital emergency medicine, and a large Nordic study that changes the way beta-blockers are used after heart attacks are among the winners.

Each year, Oslo University Hospital (OUS) bestows several awards to researchers who have distinguished themselves. This year’s winners are researchers on heart disease, DNA reparation and autoimmune diseases.

She is being distinguished for her innovative work with immunotherapy and her groundbreaking ability to find cancer's weak points, bringing the findings to patients.

Antibiotic resistance is considered one of the ten greatest global health challenges. Jukka Corander is awarded NOK 28 million to continue investigating how strains of E. coli bacteria compete with one another in the human gut.

A new study co-led by researchers at the Norwegian Centre for Molecular Biosciences and Medicine (NCMBM), and at the University of Helsinki has identified the protein SIT1 as a critical regulator of T cell activation and immune balance in humans. The findings, published in the Journal of Allergy and Clinical Immunology, provide important new insights into how the immune system is controlled and how disruptions in these mechanisms can contribute to immunodeficiency and cancer.

This study is the result of an international collaboration between researchers from Finland, Norway, Germany, and Austria.

Professor and Centre Director at PRIMA, Karl-Johan Malmberg, receives FRIPRO funding to research a type of immune cells called NK cells (Natural Killer cells), with a goal of developing new cancer treatments.

Through a groundbreaking collaboration, the University of Oslo (UiO) and the National Institute of Mental Health and Neuro Sciences (NIMHANS) in India will investigate cultural and biological causes of psychiatric conditions.

Professor Annetine Staff has received 12 million Norwegian kroner (approx. 1.1 million EUR) from the Research Council of Norway to examine how different pregnancy outcomes affect women’s hearts.

Professor Karl-Johan Malmberg has been awarded the Swedish recognition for his research on cell-based immunotherapy for blood cancers.

A new project at the University of Oslo (UiO) will investigate how our health in our 40s–60s affects the risk of dementia later in life. The MetaBrain project is funded by the Novo Nordisk Foundation.

Networks linked to UiO’s core facility for human pluripotent stem cells have received an award for their service to stem cell research. Hege Brincker Fjerdingstad and Joel Glover are delighted award recipients.